Ignite Creation Date:
2024-05-06 @ 3:59 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04827069
Status:
COMPLETED
Last Update Posted:
2022-08-12
First Post:
2021-03-22
Brief Title:
A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid LeukemiaAML
Sponsor:
Sunshine Lake Pharma Co Ltd
Organization:
Sunshine Lake Pharma Co Ltd
Organization Data
Organization:
Sunshine Lake Pharma Co Ltd
Class:
INDUSTRY
Study ID:
PCD-DHEC73543-16-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sunshine Lake Pharma Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None